Literature DB >> 15546550

Prevalence of malignancy within cytologically indeterminate thyroid nodules.

Barbara Miller1, Shelby Burkey, Guy Lindberg, William H Snyder, Fiemu E Nwariaku.   

Abstract

BACKGROUND: The optimal management of cytologically indeterminate thyroid nodules is controversial given the variable malignancy rates reported in this patient population. We examined the prevalence of malignancy within cytologically indeterminate follicular thyroid lesions in an attempt to predict malignancy based on cytologic features.
METHODS: Cytopathology reports obtained after fine-needle aspiration biopsy (FNAB) examination of indeterminate follicular thyroid lesions were examined over a 4-year period. The prevalence of malignancy on final histology was determined in 4 indeterminate cytologic categories.
RESULTS: A total of 107 records were available (91 women, 16 men). The mean patient age was 45.4 +/- 16 years. Forty-eight patients (45%) underwent surgery and had histopathologic diagnosis, while 57 patients did not have surgery. The prevalence of malignancy in patients who underwent thyroidectomy was 42% (20 of 48).
CONCLUSIONS: The high prevalence of malignancy within indeterminate follicular lesions may necessitate thyroidectomy for patients with indeterminate follicular lesions on FNAB examination.

Entities:  

Mesh:

Year:  2004        PMID: 15546550     DOI: 10.1016/j.amjsurg.2004.07.006

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  27 in total

1.  Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies.

Authors:  Meredith A Kato; Daniel Buitrago; Tracy-Ann Moo; Xavier M Keutgen; Raza S Hoda; Joseph A Ricci; Paul J Christos; Grace Yang; Thomas J Fahey; Rasa Zarnegar
Journal:  Ann Surg Oncol       Date:  2011-03-22       Impact factor: 5.344

2.  Role of sonographic diagnosis in managing Bethesda class III nodules.

Authors:  D W Kim; E J Lee; S J Jung; J H Ryu; Y M Kim
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

3.  Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results.

Authors:  Seong-Jang Kim; Samuel Chang
Journal:  Endocrine       Date:  2015-05-07       Impact factor: 3.633

4.  Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid.

Authors:  Ryan Carr; Berrin Ustun; David Chhieng; Kevin Schofield; Constantine Theoharis; Lynwood Hammers; Adebowale J Adeniran
Journal:  Endocr Pathol       Date:  2013-06       Impact factor: 3.943

5.  Do sonographic and cytological features predict malignancy in cytologically indeterminate thyroid nodules?

Authors:  S Dutta; M A Thaha; D M Smith
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

6.  The Need for Completion Thyroidectomy in Cases of Differentiated Thyroid Cancer.

Authors:  Bayram Veyseller; Alper Yenigun; Fadlullah Aksoy; Aysenur Meric; Orhan Ozturan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-17

7.  Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.

Authors:  Yong Joon Suh; Yeon Ju Choi
Journal:  Endocrine       Date:  2020-04-15       Impact factor: 3.633

8.  The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.

Authors:  Colleen M Kiernan; J T Broome; C C Solórzano
Journal:  Ann Surg Oncol       Date:  2014-05-06       Impact factor: 5.344

9.  Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers.

Authors:  Ramesh Paudyal; Yonggang Lu; Vaios Hatzoglou; Andre Moreira; Hilda E Stambuk; Jung Hun Oh; Kristen M Cunanan; David Aramburu Nunez; Yousef Mazaheri; Mithat Gonen; Alan Ho; James A Fagin; Richard J Wong; Ashok Shaha; R Michael Tuttle; Amita Shukla-Dave
Journal:  NMR Biomed       Date:  2019-11-04       Impact factor: 4.044

10.  Can CD10 be used as a diagnostic marker in thyroid pathology?

Authors:  Gülçin Yegen; Mehmet Akif Demir; Yeşim Ertan; Olcay Ak Nalbant; Müge Tunçyürek
Journal:  Virchows Arch       Date:  2008-11-25       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.